![Maria Gabriella Camboni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Gabriella Camboni
Directeur Général chez
Nephris Srl
Profil
Maria Gabriella Camboni is the founder.
At EOS SpA, served as Vice President-Development from 2006 to 2009.
Dr. Camboni is also the founder of Novuspharma SpA. Current jobs include Chief Executive Officer & Director at Nephris Srl, Chairman at Amypopharma Srl, and Non-Executive Director at MISSION Therapeutics Ltd. Former jobs include Chief Executive Officer & Director at PinCell Srl from 2020 to 2022, Independent Director at Stallergenes SA, Head-Medical Affairs Europe at Novartis Oncology, Inc., Clinical Project Leader at Sandoz SpA, and Head-Clinical Oncology at Roche Diagnostics Corp.
Education includes a doctorate from the University of Milan.
Postes actifs de Maria Gabriella Camboni
| Sociétés | Poste | Début |
|---|---|---|
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Directeur/Membre du Conseil | - |
Amypopharma Srl
 Amypopharma Srl BiotechnologyHealth Technology Operates as a biotech start-up company that develop functionalized nanoliposomes for new therapeutic approaches to treat protein misfolding disorders | Président | - |
Nephris Srl
 Nephris Srl Miscellaneous Commercial ServicesCommercial Services Develops therapies for chronic kidney disease in patients with diabetes | Directeur Général | - |
Anciens postes connus de Maria Gabriella Camboni
| Sociétés | Poste | Fin |
|---|---|---|
PinCell Srl
 PinCell Srl BiotechnologyHealth Technology Develops first in class treatments for orphan skin diseases by targeting novel pathways involved in the pathomechanism | Directeur Général | 19/01/2022 |
Novuspharma SpA
 Novuspharma SpA Pharmaceuticals: MajorHealth Technology Researches treatments for cancer and develops pharmaceuticals related to cancer treatments | Fondateur | 27/07/2011 |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Corporate Officer/Principal | - |
Sandoz SpA
 Sandoz SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
| STALLERGENES | Directeur/Membre du Conseil | - |
Formation de Maria Gabriella Camboni
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novuspharma SpA
Novuspharma SpA Pharmaceuticals: MajorHealth Technology Researches treatments for cancer and develops pharmaceuticals related to cancer treatments | Health Technology |
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergy-related respiratory diseases | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Health Technology |
University of Milan
 University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EOS SpA
 EOS SpA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Sandoz SpA
Sandoz SpA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Health Technology |
Amypopharma Srl
Amypopharma Srl BiotechnologyHealth Technology Operates as a biotech start-up company that develop functionalized nanoliposomes for new therapeutic approaches to treat protein misfolding disorders | Health Technology |
PinCell Srl
PinCell Srl BiotechnologyHealth Technology Develops first in class treatments for orphan skin diseases by targeting novel pathways involved in the pathomechanism | Health Technology |
Nephris Srl
Nephris Srl Miscellaneous Commercial ServicesCommercial Services Develops therapies for chronic kidney disease in patients with diabetes | Commercial Services |
